ArticleDiabetology & metabolic syndrome2025
Comparative analysis of 16 baseline obesity and lipid-related indices for cardiovascular disease risk prediction in adults with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study.
Article in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Association between triglyceride-glucose-related indices and cardiovascular disease risk in population with cardio-kidney-metabolic syndrome stages 0-3: a systematic review and meta-analysis.BMC cardiovascular disorders · 2026Pooled it
- Associations of triglyceride-glucose-related composite obesity indices with cardiovascular diseases and mortality: a systematic review and meta-analysis.Cardiovascular diabetology · 2026Pooled it
- Linking the triglyceride-glucose index to major adverse cardiocerebrovascular events in individuals with cardiovascular-kidney-metabolic syndrome: insights from an aggregate-data systematic review and dose-response meta-analysis.Frontiers in endocrinology · 2026Pooled it
- Long-term cumulative exposure and change patterns of CTI-FI predict the risk of cardiometabolic multimorbidity in middle-aged and older Chinese adults.Journal of diabetes and metabolic disorders · 2026Article
- Associations of cumulative exposure and dynamic trajectories of the cholesterol-HDL-glucose index and its obesity-related derivatives with cardiovascular disease: a nationwide prospective cohort study.Cardiovascular diabetology · 2026Article
- Relationship between depressive symptom trajectories and cardiovascular disease risk in middle-aged and older adults with cardiovascular-kidney-metabolic syndrome stages 0-3.BMC cardiovascular disorders · 2026Article
- Cardiovascular-kidney-metabolic syndrome: a comprehensive review of pathophysiology, epidemiology, diagnosis, and management.Cardiovascular diabetology · 2026Review
- Associations of visceral fat accumulation with cardiovascular disease across cardiovascular-kidney-metabolic syndrome stages 0-3: mediation effects of arterial stiffness in a prospective cohort study.BMC cardiovascular disorders · 2026Article
- Triglyceride-glucose index and mortality in critically ill patients with cardiovascular-kidney-metabolic syndrome stage 4.Cardiovascular diabetology · 2026Article
- Association of C-reactive protein-triglyceride-glucose index with all-cause and cardiovascular mortality in postmenopausal women.Przeglad menopauzalny = Menopause review · 2025Article
- Non-linear relationship between the triglyceride glucose-a body shape index and stroke risk: a prospective cohort study from the China health and retirement longitudinal study.Diabetology & metabolic syndrome · 2025Article
- Mediterranean diet adherence and tirzepatide: real-world evidence on adiposity indices and insulin resistance beyond weight loss.Frontiers in endocrinology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveIn the context of the newly defined cardiovascular-kidney-metabolic (CKM) syndrome, this study aimed to systematically compare the predictive value of 16 different obesity- and lipid-related indices for new-onset cardiovascular disease (CVD) in a population with CKM stages 0-3.
methodsThis prospective cohort study utilized data from the China Health and Retirement Longitudinal Study (CHARLS). A total of 5,782 participants aged 45 and older, free of CVD at baseline and classified within CKM stages 0-3, were included. We evaluated 16 indices, including traditional markers (e.g., BMI, WHtR) and novel composite markers (e.g., TyG-WC, CVAI, CTI). The primary outcome was incident CVD over a 6-year follow-up. Cox proportional hazards models were used to assess associations. Predictive performance was compared using the C-index, Akaike Information Criterion (AIC), Integrated Discrimination Improvement (IDI), and Decision Curve Analysis (DCA).
resultsDuring the 6-year follow-up, 1,134 incident CVD events occurred. In the fully adjusted Cox model, the triglyceride-glucose waist circumference index (TyG-WC) demonstrated the strongest association with CVD risk, with each 1-standard deviation increase corresponding to a 15% higher risk (HR = 1.15, 95% CI: 1.08-1.22, P < 0.001). A prediction model incorporating TyG-WC showed the best performance, with a higher C-index (0.6434), a significant improvement in discrimination (IDI = 0.0035, P < 0.001), and the greatest net benefit in Decision Curve Analysis. The findings remained robust in both landmark and sensitivity analyses.
conclusionThis study, based on nationally representative CHARLS cohort data, systematically compared the CVD risk prediction ability of 16 obesity and lipid-related indices in adults with CKM stages 0-3. The study found that the TyG-WC index demonstrated the strongest CVD risk prediction ability. These indices provide effective assessment tools for CVD risk stratification in CKM stages 0-3 populations through different pathophysiological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.